|
⚲
|
| Keyboard |
| Novo A/S
✚
|
|
|---|---|
| CIK # | 0001388325 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Edgewise Therapeutics Inc | 0.2 | ||
| Brookfield Asset Management Inc | 0.1 | ||
| ASML Holding NV | 0.1 | ||
| Mirum Pharmaceuticals Inc | 0.1 | ||
| Maplight Therapeutics Inc | 0.1 | ||
| Salesforce Com Inc | 0.1 | ||
| Crinetics Pharmaceuticals Inc | 0.1 | ||
| Imara Inc | 0.1 | ||
| Vaxcyte Inc | 0.0 | ||
| Pharvaris NV | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001388325] | |
| 3 | [0001388325] | |
| 4 | [0001388325] | |
| SC 13D | [0001388325] | |
| SC 13G | [0001388325] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MapLight Therapeutics Inc MPLT
Voting Common Stock
|
2025-10-28 | Conversion | 2,733,681 | ||
|
MapLight Therapeutics Inc MPLT
Series D Preferred Stock · derivative
|
2025-10-28 | Conversion | 19,734,671 | $0.00 | |
|
MapLight Therapeutics Inc MPLT
Series C Preferred Stock · derivative
|
2025-10-28 | Conversion | 26,191,207 | $0.00 | |
|
MapLight Therapeutics Inc MPLT
Voting Common Stock
|
2025-10-28 | Buy | 952,941 | $17.00 | 16,199,997 |
|
IO Biotech Inc IOBT
COMMON STOCK
|
2024-07-26 | Sell | 23,478 | $1.31 | 30,756 |
|
IO Biotech Inc IOBT
COMMON STOCK
|
2024-07-25 | Sell | 51,522 | $1.33 | 68,524 |
|
IO Biotech Inc IOBT
COMMON STOCK
|
2024-05-10 | Sell | 658,809 | $1.22 | 803,747 |
|
Spruce Biosciences Inc SPRB
COMMON STOCK
|
2024-03-21 | Sell | 465,021 | $0.75 | 348,766 |
|
Spruce Biosciences Inc SPRB
COMMON STOCK
|
2024-03-20 | Sell | 359,979 | $0.73 | 262,785 |
|
Spruce Biosciences Inc SPRB
COMMON STOCK
|
2024-03-19 | Sell | 593,000 | $0.76 | 450,680 |
|
Spruce Biosciences Inc SPRB
COMMON STOCK
|
2024-03-18 | Sell | 842,020 | $0.77 | 648,355 |
|
Spruce Biosciences Inc SPRB
COMMON STOCK
|
2024-03-14 | Sell | 1,912,316 | $0.89 | 1,701,961 |
|
Metagenomi Therapeutics Inc MGX
SERIES B PREFERRED STOCK · derivative
|
2024-02-13 | Conversion | 147,415 | ||
|
Metagenomi Therapeutics Inc MGX
SERIES B-1 PREFERRED STOCK · derivative
|
2024-02-13 | Conversion | 691,760 | ||
|
Metagenomi Therapeutics Inc MGX
COMMON STOCK
|
2024-02-13 | Buy | 800,000 | $15.00 | 12,000,000 |
|
Metagenomi Therapeutics Inc MGX
COMMON STOCK
|
2024-02-13 | Conversion | 839,175 | ||
|
IO Biotech Inc IOBT
COMMON STOCK
|
2024-02-09 | Sell | 658,809 | $1.50 | 988,214 |
|
Metagenomi Therapeutics Inc MGX
COMMON STOCK
|
2024-02-09 | Buy | 100,000 | $10.25 | 1,025,000 |
|
IO Biotech Inc IOBT
Common Stock
|
2023-08-09 | Buy | 2,469,135 | $2.03 | 5,012,344 |
|
IO Biotech Inc IOBT
Common Stock Warrant (Right to Buy) · derivative
|
2023-08-09 | Buy | 2,469,135 | $2.03 | 5,012,344 |
| showing 20 of 200 most recent transactions | |||||